SCM
ASLN
Sio Capital Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-254,150
| Closed | -$76.2K | – | 57 |
|
2024
Q2 | $76.2K | Hold |
254,150
| – | – | 0.02% | 43 |
|
2024
Q1 | $156K | Hold |
254,150
| – | – | 0.05% | 45 |
|
2023
Q4 | $133K | Hold |
254,150
| – | – | 0.03% | 35 |
|
2023
Q3 | $478K | Hold |
254,150
| – | – | 0.15% | 43 |
|
2023
Q2 | $928K | Hold |
254,150
| – | – | 0.24% | 29 |
|
2023
Q1 | $732K | Sell |
254,150
-1,016,608
| -80% | -$2.93M | 0.36% | 35 |
|
2022
Q4 | $457K | Hold |
1,270,758
| – | – | 0.17% | 34 |
|
2022
Q3 | $761K | Hold |
1,270,758
| – | – | 0.24% | 33 |
|
2022
Q2 | $629K | Hold |
1,270,758
| – | – | 0.24% | 44 |
|
2022
Q1 | $1.14M | Hold |
1,270,758
| – | – | 0.38% | 43 |
|
2021
Q4 | $1.42M | Hold |
1,270,758
| – | – | 0.43% | 49 |
|
2021
Q3 | $2.26M | Sell |
1,270,758
-217,750
| -15% | -$388K | 0.72% | 39 |
|
2021
Q2 | $4.91M | Buy |
1,488,508
+40,000
| +3% | +$132K | 1.22% | 25 |
|
2021
Q1 | $4.85M | Buy |
1,448,508
+55,854
| +4% | +$187K | 0.99% | 31 |
|
2020
Q4 | $2.55M | Buy |
1,392,654
+15,700
| +1% | +$28.7K | 0.52% | 57 |
|
2020
Q3 | $2.62M | Hold |
1,376,954
| – | – | 0.52% | 48 |
|
2020
Q2 | $2.75M | Buy |
1,376,954
+82,043
| +6% | +$164K | 0.8% | 42 |
|
2020
Q1 | $1.32M | Buy |
1,294,911
+276,940
| +27% | +$283K | 0.44% | 44 |
|
2019
Q4 | $2.07M | Buy |
+1,017,971
| New | +$2.07M | 0.49% | 39 |
|